Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 1/20 | 0.50 |
| ▸ | TLR4 | O00206 | 6/20 | 0.49 |
| ▸ | LY96 | Q9Y6Y9 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TK2 | O00142 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3388845 | 1.00 | GJB2 (0.50) | GJB2TLR4LY96KDM4EPOLB | |
| SCHEMBL4185267 | 1.00 | GJB2 (0.50) | GJB2TLR4LY96KDM4EPOLB | |
| SCHEMBL4185389 | 1.00 | GJB2 (0.50) | GJB2TLR4LY96KDM4EPOLB | |
| SCHEMBL4181281 | 1.00 | GJB2 (0.50) | GJB2TLR4LY96KDM4EPOLB | |
| SCHEMBL4199466 | 1.00 | GJB2 (0.50) | GJB2TLR4LY96KDM4EPOLB | |
| SCHEMBL2959757 | 0.93 | TLR4 (0.54) | GJB2TLR4 | |
| SCHEMBL4199470 | 0.93 | LGALS8 (0.50) | GJB2TLR4LY96TK2 | |
| SCHEMBL4185394 | 0.93 | LGALS8 (0.50) | GJB2TLR4LY96TK2 | |
| SCHEMBL3393533 | 0.93 | LGALS8 (0.50) | GJB2TLR4LY96TK2 | |
| SCHEMBL4181285 | 0.93 | LGALS8 (0.50) | GJB2TLR4LY96TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116640756-A | Heparinase I protective agent and application thereof in thromboelastography heparin detection kit | 上海太阳生物技术有限公司 | 2023-08-25 | — | — | CN | claimed |
| EP-2314351-B1 | Hair dye agent with improved skin tolerance | HENKEL AG & CO KGAA (DE) | 2014-12-17 | — | — | EP | claimed |
| CN-118307606-A | Trehalose ester and preparation, purification and decoloration methods and application thereof | 南京华狮新材料有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-117379356-B | Nose protecting ointment and preparation method thereof | 乐比(广州)健康产业有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117379356-A | Nose protecting ointment and preparation method thereof | 乐比(广州)健康产业有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116640756-A | Heparinase I protective agent and application thereof in thromboelastography heparin detection kit | 上海太阳生物技术有限公司 | 2023-08-25 | — | — | CN | disclosed |
| US-20230265614-A1 | WATER INSOLUBLE, HIGH MELTING POINT SACCHARIDE FATTY ACID ESTERS (SFAE) | GREENTECH GLOBAL PTE. LTD. (SG) | 2023-08-24 | — | — | US | disclosed |
| CN-116536379-A | Preparation method and application of trehalose fatty acid monoester and diester | 暨南大学 | 2023-08-04 | — | — | CN | disclosed |
| CN-101687167-B | W/O/W type emulsified composition | NISSHIN OILLIO GROUP LTD | 2012-10-03 | — | — | CN | disclosed |
| US-20100099646-A1 | W/O/W EMULSION COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2172263-A1 | W/O/W EMULSION COMPOSITION | The Nisshin OilliO Group, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | IKEMOTO TAKESHI | 2007-07-12 | — | — | US | disclosed |
| US-20050220726-A1 | Use of sugar esters in cosmetic and/or pharmaceutical preparations | COGNIS FRANCE S.A. (FR) | 2005-10-06 | — | — | US | disclosed |
| US-20040022819-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | KAO CORPORATION (JP) | 2004-02-05 | — | — | US | disclosed |
| US-6497898-B1 | STABILITY, DRUG AND COSMETIC DELIVERY | KANEBO LTD (JP) | 2002-12-24 | — | — | US | disclosed |
| EP-0729781-B1 | LIPOSOME COMPRISING A MEMBRANE WALL COMPOSED OF A TREHALOSE FATTY ACID ESTER | KANEBO LTD (JP) | 2002-08-07 | — | — | EP | disclosed |
| US-5721109-A | DETECTION OF ANTIBODIES TO ACID-FREE BACTERIUM ANTIGEN | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1998-02-24 | — | — | US | disclosed |
| EP-0729781-A1 | SURFACTANT, AND EMULSION COSMETIC AND LIPOSOME EACH CONTAINING THE SAME | Ikemoto, Takeshi (JP) | 1996-09-04 | — | — | EP | disclosed |
| EP-0407605-B1 | USE OF A REAGENT FOR DETECTING ANTIBODY CORRESPONDING TO ACID-FAST BACTERIUM ANTIGEN | SAWAI SEIYAKU KK (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0407605-A1 | USE OF A REAGENT FOR DETECTING ANTIBODY CORRESPONDING TO ACID-FAST BACTERIUM ANTIGEN | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040022819-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | GJB2 4049/4885TLR4 451/4885LY96 103/4885 |
| US-20070160556-A1 | Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant | TREH, LIPA, CUTA | GJB2 4097/4885TLR4 477/4885LY96 81/4885 |
| US-20050220726-A1 | Use of sugar esters in cosmetic and/or pharmaceutical preparations | CUTA, SUCLG1, TREH | GJB2 3366/4885TLR4 2866/4885LY96 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.